In fact, the suboptimal glycaemic control could lead to a higher incidence of foetal macrosomia and other composite outcomes [24] in the same way by which GDM treatments limited to standard diet therapy [25] and routine care [26] determine when compared to GDM insulin treatment. This evidence concerns the gene INS and gestational diabetes.